Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-randomised, Non-inferiority Clinical Trial in South Kivu, DR Congo

NCT02741024 is registered in ClinicalTrials.gov with Medecins Sans Frontieres, Netherlands as lead sponsor.

NCT NCT02741024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02741024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-randomised, Non-inferiority Clinical Trial in South Kivu, DR Congo
Lead sponsor
Medecins Sans Frontieres, Netherlands
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2014
Enrollment
288 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria